1 |
Modernization of manufacturing and evaluation operation of drugs using the state of art technology |
AICTE-MODROBS |
January 2000 to December 2003 |
7.00 |
Completed |
2 |
Study on polymeric ophthalmic inserts of natural forskolin and forskolin analogue in the treatment of glucoma |
AICTE- R & D |
2004 to 2007 |
3.65 |
Completed |
3 |
Establishment of Pharmacokinetic laboratory operations for herbal drugs using the state of art technology conforming GLP regulations |
AICTE- NAFETEC |
January 2007 to December 2010 |
58.00 |
Completed |
4 |
Effective Management of Multi-factorial Alzheimer’s disease: An Attempt of Nano-structured lipid Carriers containing Donepezil and Curcumin through Olfactory to Brain |
DST-Science & Engineering Research Board (SERB). |
October 2015
To
September 2016
|
11.80 |
Completed |
5 |
Lipids for nano formulations characterization of the nano formulations cell lines, media, FBS |
JSS University Research Grants |
June 2014 to June 2016 |
0.50 |
Completed |
6 |
Improving the Delivery of poorly soluble Drugs through Nanotechnology |
Carrier Award for Young Teachers(CAYT), AICTE |
January 2014 to 2018 |
1.05 |
Completed |
7 |
Lipid Conjugated Carbons Nano tubes for Receptor Targeted Delivery to Breast Cancer |
JSS University Research Grants |
11th August 2017 to
12th August 2019
|
0.50 |
Completed |
8 |
Investigation of the Therapeutic potential of capecitabine Nano particles linked to the Novel Peptide binds to breast cancer |
JSS University Research Grants |
12th August 2017 to
12th August 2020
|
0.50 |
Completed |
9 |
Engineered affibody conjugated oxaliplatin nano particles for the management of colorectal cancer |
AICTE-RPS |
October 2017 to September 2020 |
5.00 |
Completed |
10 |
Patient centric centre customized drug delivery systems |
DST-FIST (Level I) |
January 2018- December 2024 |
58.00 |
Ongoing |
11 |
TRAIL Conjugated Oxaliplatin Hybrid Drug Delivery for Targeting DR4 and DR5 Receptor for Management of Colorectal Cancer |
DBT-NER |
January 2021 to January 2023
|
33.43 |
Ongoing |
12 |
Management of diabetic foot ulcers using collagen-chitosan
acellular dermal matrix impregnated with nano antimicrobial peptide
|
JSS University Research Grants |
Sep 2019 – Aug 2023
|
0.50 |
Ongoing |
13 |
Study on influence of genetic polymorphisms on pharmacokinetic and pharmacodynamics effect of dabigatran etexilate in south Indian population
|
JSS University Research Grants |
Oct 2019 – Aug 2023
|
0.50 |
Ongoing |
14 |
Surface modification of dendrimers for breast cancer targeted drug delivery
|
JSS University Research Grants |
2019 – 2020
|
0.50 |
Completed |
15 |
Nanotheranostics for CVD disease management
|
DBT-RRSFP- BUILDER
In ASSOCIATION
|
Mar 2021 – Feb 2025
|
1000 |
Ongoing |
16 |
Lipid-Based Nano
formulation approach to
target brain for the
management of
tuberculosis through
intranasal delivery:
Formulation development
and evaluation
|
JSS University Research Grants |
Feb 2020-Feb 2023
|
0.25 |
Ongoing |
17 |
Development of NLC for
seizures activation therapy
through prodrug approach
|
JSS University Research Grants |
Feb 2020-Feb 2023
|
0.25 |
Ongoing |
18 |
Modulating the metabolic
pathway of ovarian
cancer cells through biospecific
nano drug delivery
|
JSS University Research Grants |
Feb 2020-Feb 2023
|
0.25 |
Ongoing |
19 |
Technology Development for Space Medicine
|
DST PURSE |
2022-2026
|
19 Cr |
Ongoing |
20 |
Customized drug delivery
|
Bristol Myers Squibb |
2022-2023
|
3.75L |
Ongoing |